Marango Jotin 4
4 · ImageneBio, Inc. · Filed Jul 29, 2025
Insider Transaction Report
Form 4
Marango Jotin
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2025-07-25−181,000→ 0 total→ Common Stock (181,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2025-07-25−397,199→ 0 total→ Common Stock (397,199 underlying) - Tax Payment
Common Stock
2025-07-28$17.16/sh−4,630$79,451→ 11,146 total - Award
Common Stock
2025-07-28+15,776→ 15,776 total - Disposition to Issuer
Stock Option (Right to Buy)
2025-07-25−105,000→ 0 total→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. ("Ikena")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena.